Sign inJoin waitlistJoin the waitlist

Back to Temple University Hospital-Fox Chase Cancer Center Hematology and Medical Oncology

BM

Benjamin Miron

Hematology/Oncology Fellowship · Fox Chase Cancer Center

Credentials: · ·

History

Research

A phase 2 trial of erlotinib in patients with previously treated squamous cell and adenocarcinoma of the esophagus
Cancer · 2011 · 75 citations
Defects in DNA Repair Genes Confer Improved Long-term Survival after Cisplatin-based Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer
European Urology Oncology · 2020 · First of 18 authors · 70 citations
Subclonal Therapy by Two EGFR TKIs Guided by Sequential Plasma Cell-free DNA in EGFR-Mutated Lung Cancer
Case report · Journal of Thoracic Oncology · 2017 · 41 citations

Daniel Geynisman
7 papers
Matthew Zibelman
7 papers
Elizabeth Plimack
5 papers
Fern Anari
4 papers · 1 as a fellow
Kevin Zarrabi
4 papers · 3 as a fellow
Alexander Kutikov
3 papers
Pooja Ghatalia
3 papers
Robert Uzzo
3 papers
Laura Bukavina
2 papers · 2 as a fellow
Adam Calaway
1 paper
Agreen Hadadi
1 paper · 1 as a fellow
AS
Alexey Sorokin
1 paper · 1 as a fellow

Clinical trials

A Pilot Study of Circulating Tumor DNA Adaptive Risk Maintenance Approach for Bladder Cancer (CARMA)
Principal investigator · Withdrawn · Phase 2
Fox Chase Cancer Center
2023–2032